Mr. Karl Kottmeier reports

NOTICE - CHEMISTREE CONVERTIBLE DEBENTURE INTEREST PAYMENT

Chemistree Technology Inc. is providing notice of the semi-annual payment of interest on its convertible debentures maturing March 29, 2024. Pursuant to the supplemental indenture entered into with the debenture trustee, Odyssey Trust Company, effective Jan. 17, 2022, the company will pay the interest due on Dec. 31, 2023 -- via the issuance of common shares in lieu of payment in cash.

According to data provided by the debenture trustee, $6,837,000 in convertible debentures remain outstanding. The debentures bear interest at 10 per cent per annum, paid semi-annually at the end of June and December. Common shares to be issued in satisfaction of the interest payment are calculated according to a market price formula set out in the supplemental indenture and are subject to a minimum issue price of five cents per share.

The convertible debentures accrue interest daily, with such accrued interest paid immediately upon conversion of the debentures. The principal amount of the debentures is convertible into common shares of the company at a price of 50 cents per share.

About Chemistree Technology Inc.

Chemistree is a Canadian investment company whose strategy is to focus on opportunistic investments across a broad range of industries, and is seeking to invest in early-stage, promising companies where it may be the lead investor and can additionally provide investees with advisory services, mentoring and access to the company's management expertise. Existing holdings are in a consumer-targeted biotechnology venture, a renewable energy developer in the wind and solar sector, a plant-based wellness company, and an Ontario limited partnership to take advantage of opportunistic long/short equity opportunities in both potential upside and downside expected price moves.

We seek Safe Harbor.